These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27752454)

  • 1. SVHC in imported articles: REACH authorisation requirement justified under WTO rules.
    Schenten J; Führ M
    Environ Sci Eur; 2016; 28(1):21. PubMed ID: 27752454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trade Union Priority List for REACH authorisation.
    Romano D; Santos T; Gadea R
    J Epidemiol Community Health; 2011 Jan; 65(1):8-13. PubMed ID: 20508006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consideration of criteria required for assignment of a (skin) sensitiser a substance of very high concern (SVHC) under the REACH regulation.
    Basketter D; Kimber I
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):524-8. PubMed ID: 24893346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time matters: A stock-pollution approach to authorisation decision-making for PBT/vPvB chemicals under REACH.
    Gabbert S; Hilber I
    J Environ Manage; 2016 Dec; 183():236-244. PubMed ID: 27594688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The German REACH Congress 2016: a workshop report.
    Reihlen A; Jepsen D; Broschinski L; Luch A; Schulte A
    Arch Toxicol; 2018 Mar; 92(3):1343-1347. PubMed ID: 29453549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the impact of authorisation process as a regulatory tool in the European REACH regulation: A study on improving occupational safety for applying companies.
    Deubner HL; Walendzik G; Lüdeke A; Schlüter U
    Ann Work Expo Health; 2024 Jul; 68(6):617-625. PubMed ID: 38718166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect thresholds and 'adequate control' of risks: The fatal flaws in the EU council's position on authorisation within REACH.
    Santillo D; Johnston P
    Environ Sci Pollut Res Int; 2006 Oct; 13(6):425-31. PubMed ID: 17120834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do consumers care about substances of very high concern in articles?
    Hartmann S; Klaschka U
    Environ Sci Eur; 2018; 30(1):29. PubMed ID: 30175022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PBT assessment using the revised annex XIII of REACH: a comparison with other regulatory frameworks.
    Moermond CT; Janssen MP; de Knecht JA; Montforts MH; Peijnenburg WJ; Zweers PG; Sijm DT
    Integr Environ Assess Manag; 2012 Apr; 8(2):359-71. PubMed ID: 22006646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Where are the SVHCs?: 10 years consumer's 'right to know' about substances of very high concern.
    Klaschka U
    Environ Sci Eur; 2017; 29(1):24. PubMed ID: 28794919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semipolar polycyclic aromatic compounds: identification of 15 priority substances and the need for regulatory steps under REACH regulation.
    Schwarz MA; Behnke A; Brandt M; Eisenträger A; Hassauer M; Kalberlah F; Seidel A
    Integr Environ Assess Manag; 2014 Jul; 10(3):415-28. PubMed ID: 24449130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are chemicals in articles an obstacle for reaching environmental goals? - Missing links in EU chemical management.
    Molander L; Breitholtz M; Andersson PL; Rybacka A; Rudén C
    Sci Total Environ; 2012 Oct; 435-436():280-9. PubMed ID: 22858536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rewriting the regulations: how the World Trade Organisation could accelerate privatisation in health-care systems.
    Pollock AM; Price D
    Lancet; 2000 Dec; 356(9246):1995-2000. PubMed ID: 11130537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using the WTO/TBT enquiry point to monitor tendencies in the regulation of environment, health, and safety issues affecting the chemical industry.
    Pio Borges Menezes R; Maria de Souza Antunes A
    Environ Int; 2005 Apr; 31(3):407-16. PubMed ID: 15734193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Food Safety Modernization Act: a barrier to trade? Only if the science says so.
    McNeill N
    Food Drug Law J; 2012; 67(2):177-90, ii. PubMed ID: 24620418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How do international trade obligations affect policy options for obesity prevention? Lessons from recent developments in trade and tobacco control.
    von Tigerstrom B
    Can J Diabetes; 2013 Jun; 37(3):182-8. PubMed ID: 24070841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.
    Kroes BH
    J Ethnopharmacol; 2014 Dec; 158 Pt B():449-53. PubMed ID: 25086408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does the World Trade Organization know? The mobilization and staging of scientific expertise in the GMO trade dispute.
    Bonneuil C; Levidow L
    Soc Stud Sci; 2012 Feb; 42(1):75-100. PubMed ID: 22530384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.